Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (1131-1140 of 1,281) with videos related to

Pageof 129
Sort By:
Oncotarget|March 31, 2016
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancerAdrian G Sacher, Lisa W Le, Humberto Lara-Guerra, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Induction treatment before surgery for non-small cell lung cancerW E Eberhardt, K S Albain, H Pass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18Natasha B Leighl, Luis Paz-Ares, Jean-Yves Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Three-gene prognostic classifier for early-stage non small-cell lung cancerSuzanne K Lau, Paul C Boutros, Melania Pintilie, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spineMasaki Anraku, Thomas K Waddell, Marc de Perrot, et al.
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerRuoshi Shi, Sebastiao N Martins Filho, Ming Li, et al.
Clinical and Translational Radiation Oncology|February 3, 2025
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapyAbdul H Lone, Rohan Salunkhe, Vijithan Sugumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancerJoachim von Pawel, Robert Jotte, David R Spigel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancerMartin Reck, Luis Paz-Ares, Paolo Bidoli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
A waterborne outbreak of gastroenteritis with multiple etiologies among resort island visitors and residents: Ohio, 2004Ciara E O'Reilly, Anna B Bowen, Nytzia E Perez, et al.
Pageof 129

Showing results (1131-1140 of 1,281) with videos related to

Sort By:
Pageof 129
Oncotarget|March 31, 2016
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancerAdrian G Sacher, Lisa W Le, Humberto Lara-Guerra, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Induction treatment before surgery for non-small cell lung cancerW E Eberhardt, K S Albain, H Pass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18Natasha B Leighl, Luis Paz-Ares, Jean-Yves Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Three-gene prognostic classifier for early-stage non small-cell lung cancerSuzanne K Lau, Paul C Boutros, Melania Pintilie, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spineMasaki Anraku, Thomas K Waddell, Marc de Perrot, et al.
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerRuoshi Shi, Sebastiao N Martins Filho, Ming Li, et al.
Clinical and Translational Radiation Oncology|February 3, 2025
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapyAbdul H Lone, Rohan Salunkhe, Vijithan Sugumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancerJoachim von Pawel, Robert Jotte, David R Spigel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancerMartin Reck, Luis Paz-Ares, Paolo Bidoli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
A waterborne outbreak of gastroenteritis with multiple etiologies among resort island visitors and residents: Ohio, 2004Ciara E O'Reilly, Anna B Bowen, Nytzia E Perez, et al.
Pageof 129